Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the facilitated intervention with enhanced reperfusion speed to stop events (FINESSE) trial

This publication has 30 references indexed in Scilit:

• Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
  The Lancet, 2003
• DANAMI-2: Is primary angioplasty superior to thrombolysis in acute MI when the patient has to be transferred to an invasive centre?
  International Journal of Cardiology, 2002
• Heterogeneity in the Management and Outcomes of Patients With Acute Myocardial Infarction Complicated by Heart Failure
  Circulation, 2002
• Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction
  Circulation, 2002
• Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial
  The Lancet, 2001
• Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14
  European Heart Journal, 2000
• Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction
  JACC, 2000
• Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction
  New England Journal of Medicine, 1999
• Randomized Comparison of Primary Coronary Angioplasty With Thrombolytic Therapy in Low Risk Patients With Acute Myocardial Infarction
  JACC, 1997
• Rationale, design and baseline characteristics of the survival and ventricular enlargement trial
  The American Journal of Cardiology, 1991